Notice of NINDS's Participation in RFA-MH-15-800 "Consortium on Biomarker and Outcome Measures of Social Impairment for Use in Clinical Trials in Autism Spectrum Disorder (U19)"

---

Notice Number: NOT-NS-14-045

Key Dates
Release Date: September 16, 2014

Related Announcements
RFA-MH-15-800

Issued by
National Institute of Neurological Disorders and Stroke (NINDS)

Purpose

The purpose of this Notice is to inform potential applicants of the participation by the National Institute of Neurological Disorders and Stroke (NINDS) in RFA-MH-15-800 "Consortium on Biomarker and Outcome Measures of Social Impairment for Use in Clinical Trials in Autism Spectrum Disorder (U19)".

The following sections of RFA-MH-15-800 have been updated to reflect the participation of NINDS in this FOA:

Part 1. Overview Information

Components of Participating Organizations
National Institute of Mental Health (NIMH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute of Neurological Disorders and Stroke (NINDS)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.242, 93.865, 93.853

Part 2. Section II. Award Information

Funds Available and Anticipated Number of Awards
NIMH, NICHD and NINDS intend to commit $4,050,000 in direct costs in FY 2015 to fund one award.

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Deborah G Hirtz, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5821
Email: [email protected]

Financial/Grants Management Contact(s)
Tijuanna Decoster, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-9231
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Deborah G Hirtz, M.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-5821
Email: [email protected]

---

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

---